The final thesis of Professor Lim Soo's team of the Department of Endocrine Metabolism at Bundang Seoul National University ...

Patients with asthma and T2 diabetes using SGLT2 inhibitors have a significantly decreased mortality risk within 30 days of an asthma exacerbation.

Conclusion: Sglt2 deletion did not affect salt-sensitive blood pressure elevation but attenuated high salt-induced damage in the heart and kidneys. These findings suggest that the protective effects ...

SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis. After adjustments, patients on SGLT2 inhibitors had a significantly reduced risk of progression to severe ...

“Help me please … I can’t calm down without laying on the ground and freaking out for a good 20 minutes … Should I get medical help?” This plea came from a post on the social media site Reddit. The ...

Background: Anthracyclines are essential components of chemotherapeutic regimens for a broad spectrum of malignancies, yet their utility is constrained by cumulative, dose-dependent cardiotoxicity, ...

GLP-1 drugs are a class of medication used to treat type 2 diabetes and obesity. While they are generally safe to use, they can cause side effects, such as nausea, vomiting, and diarrhea. Starting on ...

GLP-1 receptor agonists and dual agonists, such as semaglutide and tirzepatide, have become powerful tools for managing type 2 diabetes. But, like any medication, they come with side effects. From ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of sodium-glucose cotransporter 2 inhibitors was ...

Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors vs. other agents were tied to a slower eGFR decline for adults with ADPKD and type 2 diabetes.

When canagliflozin (Invokana) was approved in 2013, the SGLT2 inhibitor was touted as a first in a new medication class that was, at the time, the only oral, once-daily medication to reduce blood ...

Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors ...